Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.01 | 1.67 |
NAV | ₹14.22 | ₹214.04 |
Fund Started | 16 Aug 2022 | 20 Aug 2004 |
Fund Size | ₹2105.11 Cr | ₹15520.74 Cr |
Exit Load | Exit Load for units in excess of 25% of the investment,1% will be charged for redemption within 365 days. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 17.29% | 26.32% |
3 Year | - | 25.91% |
5 Year | - | 22.50% |
1 Year
3 Year
5 Year
Equity | 98.55% | 83.32% |
Cash | 1.45% | 16.35% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.99% |
ICICI Bank Ltd. | 7.11% |
Infosys Ltd. | 4.43% |
Reliance Industries Ltd. | 4.19% |
Larsen & Toubro Ltd. | 3.58% |
Bharti Airtel Ltd. | 3.30% |
State Bank of India | 2.85% |
Sun Pharmaceutical Industries Ltd. | 2.58% |
Tata Consultancy Services Ltd. | 2.39% |
Interglobe Aviation Ltd. | 2.27% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.49% |
ICICI Bank Ltd. | 9.21% |
Axis Bank Ltd. | 8.35% |
Maruti Suzuki India Ltd. | 4.46% |
SBI Life Insurance Company Ltd. | 4.17% |
Cipla Ltd. | 4.15% |
Kotak Mahindra Bank Ltd. | 3.98% |
HCL Technologies Ltd. | 3.81% |
Bharti Airtel Ltd. | 3.67% |
Piramal Pharma Ltd. | 3.64% |
Name | Dwijendra Srivastava | Dhruv Muchhal |
Start Date | 03 Nov 2015 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate capital appreciation by dynamically investing in a mix of equity and equity related instruments across market capitalization. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 16 Aug 2022 | 20 Aug 2004 |
Description
Launch Date